Abivax SA (AAVXF)
Abivax Market Cap : 9.156B for May 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Nicox SA | 30.94M |
| DBV Technologies SA | 1.080B |
| Cellectis SA | 394.40M |
| Transgene SA | 112.45M |
| Innate Pharma SA | 189.49M |
Market Cap Related Metrics
| Price to Book Value | 17.13 |
| Price | 115.65 |
| Earnings Yield | -4.67% |